Second Generation Proteasome Inhibitor is More Potent than Doxorubicin (Firstline Drug) in Inhibiting Proliferation and Inducing Apoptosis in Human Triplenegative Breast MDAMB231 Cancer Cells

Volume: 227, Issue: 4, Pages: e7 - e7
Published: Oct 1, 2018
Abstract
Journal of the American College of Surgeons 227(4):p e7, October 2018. | DOI:...
Paper Details
Title
Second Generation Proteasome Inhibitor is More Potent than Doxorubicin (Firstline Drug) in Inhibiting Proliferation and Inducing Apoptosis in Human Triplenegative Breast MDAMB231 Cancer Cells
Published Date
Oct 1, 2018
Volume
227
Issue
4
Pages
e7 - e7
Citation AnalysisPro
  • Scinapse’s Top 10 Citation Journals & Affiliations graph reveals the quality and authenticity of citations received by a paper.
  • Discover whether citations have been inflated due to self-citations, or if citations include institutional bias.